Live Breaking News and Articles From the Pharmaceutical Industry

Pharmaceutical News on Ulitzer

Subscribe to Pharmaceutical News on Ulitzer: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Pharmaceutical News on Ulitzer: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Top Stories

He's been doing it again. Blogging, that is. And, as usual, Sun's president and COO zeroes in on the main issue that makes the software industry the endlessly fascinating place it is, anno 2004, namely the choice between proprietary and open source solutions. It's not an either/or choice, Schwartz contends, and refers to a surprising moment that happened at Sun's JavaOne developer conference earlier this year. "A bunch of friends joined us for a discussion on the open sourcing of Java," writes Schwartz in the latest entry in his widely-read blog: "Among the luminaries present was Brian Behlendorf, who opened his statements by asking what I'm sure he felt was a question with a popular answer, 'How many of you work on an open source project?' I expected to see a flurry of hands, and I'm sure he did, too. Neither of us saw hands go up." Schwartz cites this as just one ex... (more)

Are Enterprises Ready for Cloud Computing?

Barry Lynn's Blog There have been multiple white papers and articles written by analysts - Is Cloud Computing Ready for the Enterprise? The question is asked so many times now - Is Cloud Computing ready for the enterprise? So, I have to ask - Is the enterprise ready for Cloud Computing? I’ll start this discourse with a few PC and sincere comments (the two are not mutually exclusive unless one is running for political office). First, I love Corporate CIOs and IT managers (not in a romantic way, of course, but with great admiration). Second, they have the most difficult jobs in the corporate universe. They are the brains and the central nervous systems of large enterprises. They are also the most taken for granted of all executives. They represent cost centers who get no credit for their corporations’ profits, while keeping the corporation alive. If they achieve 99.99%... (more)

TIBCO Spotfire in Life Sciences

Oracle Keynote at Cloud Expo October 19, 2009 - TIBCO Software announced a strategic push to extend its leadership position in the global life sciences market with the release of several research and clinical analysis solutions, including Integromics Biomarker Discovery 2.0 for TIBCO Spotfire, TIBCO Spotfire Lead Discovery 2.0, TIBCO Spotfire Pipeline Pilot Connector, and TIBCO Spotfire Clinical Graphics 2.0. These solutions deliver integrated informatics and analysis, are central to research & development efforts in the life sciences industry and can transform the process of bringing life-saving medicines to market. Access to actionable knowledge early in the commercialization process of a new drug can lead to better safety outcomes for patients, and better regulatory and commercial outcomes for the industry. The TIBCO Spotfire Enterprise Analytics Platform is de... (more)

Aimia Acquires Excellence in Motivation

MONTREAL and DAYTON, Ohio, Aug. 28, 2012 /PRNewswire/ -- Aimia (TSX: AIM), a global leader in loyalty management headquartered in Montreal, Canada, today announced that it has entered into an agreement to purchase Excellence In Motivation Inc. (EIM), a privately-owned U.S.-based full-service performance improvement and business loyalty solutions provider, for approximately US $28 million. The transaction is subject to customary closing conditions and is expected to close by the end of September 2012. The acquisition will be financed with cash on hand.  The acquisition is part of Aimia's global growth strategy, which includes investing in opportunities that complement its business, accelerating its presence in the U.S. market. The transaction will strengthen Aimia's presence in key vertical markets, including automotive, healthcare, pharmaceutical, high tech and te... (more)

Digital Transformation Moves Pharma “Beyond the Pill”

Digital Transformation Moves Pharma “Beyond the Pill” The Internet of Things (IoT) is getting personal. Wearables, ingestables, even implantables – devices that not only help us with our fitness, but can monitor and manage disease and its treatment – are right around the corner. And where the IoT goes, money follows. In this case, Big Pharma smells opportunity. But while these new consumer doodads get all the press, health-related IoT technologies are only the tip of the iceberg for the Digital Transformation hitting the pharmaceutical industry, as it struggles with a turbulent business landscape. “There are very few blockbuster drugs,” explains Eric Pilkington, EVP Digital Strategy at McCann Health North America. “The pharma companies are trying to figure out what to do. The competitors are the generics: identical and cheaper. The pharmas have to provide value beyo... (more)

Sun's Blade Ain't Too Sharp

(February 17, 2003) - Sun Microsystems Monday became the last of the majors to finally buckle on blades and in the view of its rivals skated right on to thin ice. As a proof point, Debbie Miller and Susan Davis, respectively the president and VP of product marketing of Egenera, a three-old blade start-up that Sun should theoretically be wiping the floor with, called the new Sun Fire Blade Platform "pitiful."  Huh?  You mean they're not cowering in fear? Evidently not and evidently it's not just an estrogen* rush. Egenera, which has been specifically targeting Sun installations, just can't imagine who's gonna buy the Sun stuff. What Sun wants to put on the market, the Egenera ladies observed, is the equivalent of what blade pioneer RLX Technologies had two or three years ago when it was practically laughed out of town for being wimpy.  The ladies figure Sun must have... (more)

Oracle Focuses on Life Sciences at OpenWorldLeading Software Solutions Provider Helps Biosciences, Genomic, Pharmaceutical Firms

(San Francisco) –Speaking at Oracle OpenWorld's inaugural Life Sciences Day on December 4, Lawrence J. Ellison, chairman and CEO of Oracle Corporation, extolled the life sciences industry for engineering quantum leaps in scientific knowledge and drug therapy, and reaffirmed Oracle's long-standing commitment to facilitate the valuable research and discovery efforts of biosciences, genomic and pharmaceutical companies. Working with leaders in the life sciences field for more than a decade, Oracle has developed an integrated, end-to-end information-management solution to meet needs of this rapidly growing industry. With more than 65 per cent of life sciences companies running Oracle technology -- including Fortune 500's top 10 pharmaceutical/biotech companies -- Oracle is uniquely positioned to support the massively data-intensive lifecycles of new products, and enabl... (more)

Oracle Purchases TopLink, Offers Free Download to Power Java Productivity

Oracle has purchased the TopLink family of products, developed and supported out of WebGain Canada, a division of WebGain Inc. of Santa Clara, CA. The acquisition includes the TopLink technology, the TopLink family of products and all TopLink employees (about 90 in all, including all WebGain Canada staff and some employees in the San Francisco and Raleigh, NC offices). The deal was final on June 13, 2002. One of Oracle's key objectives is to provide productive and high performance solutions to the Java/J2EE Java development community. TopLink products fill a critical need for storing business objects and components in a relational database (RDB), while maximizing Java developer productivity. Developers can expect to save 30-40 percent of project resources using this Object-Relational mapping software product. There are 700 licensed TopLink customers, of which 400 we... (more)

Wi-Fi with Your Big Mac, Sir?

IBM thinks what you need with your Big Mac is Wi-Fi connectivity, so they are deploying access points in McDonald's restaurants across the U.S., starting in New York City. This is being done under the Cometa brand, the alliance between IBM, AT&T, and Intel on the technical side, with 3i and Apex providing the finance. Always keen to combine fast food with fast-network access, WBT's Editor-in-Chief, Bill Ray, tracked down Dean Douglas, VP for the Telecommunications Industry, IBM Global Services, to talk about Wi-Fi, burgers, and the problems of cleaning ThinkPads... WBT: So you're planning to deploy Wi-Fi hotspots in McDonald's restaurants - how many and where? Is the plan to eventually go in to every one, or just selected sites? What's the timeframe involved? DOUGLAS: Initially, we worked in conjunction with Cometa Networks to make Wi-Fi available at 10 McDonald's lo... (more)

The Life Sciences Revolution

In the past few years we've seen a revolution taking place in the life sciences, a revolution driven by information technology, which has become the engine of experimental biology. As a result, we are seeing the convergence of information technology and the biological sciences, a convergence that will affect the way we live and that holds the potential to greatly improve the quality and effectiveness of medical care. Perhaps the term "life sciences" is new to you. The life sciences market includes the pharmaceutical, biotechnology, genomic, e-health, and agri-science industries. This market is essentially dedicated to drug discovery, to understanding genomics, proteomics, structural biology, and emerging areas associated with the study of metabolic regulation, as well as focusing on improving health care as we move toward e-health. The focus by IT vendors on the lif... (more)

BEA Founder's New Dream: Cassatt to Unveil the Next Great Paradigm

Cassatt Corporation, the glitterati start-up headed by BEA co-founder and ex-CEO Bill Coleman, is a bit sheepish about phrasing it quite like this, but the company thinks it's about to unleash the "next wave of computing." Its problem is giving this next wave of computing a name. There's no clear category or snug harbor Cassatt can tuck its products in just yet to make its positioning easier. Its aim is to calm the "perfect storm" that commoditization has wrought in the data center and manage the chaotic pile of scaled-out commodity servers brought in to replace the data center's once vaunted proprietary systems. Cassatt thinks it can do what IBM's utility computing and on-demand initiatives, as well as HP's Adaptive Enterprise, have promised to do, but haven't done irrespective of the underlying hardware, and certainly haven't done without adding complexity to comple... (more)